MedPath

application of guduchi ghrita as eye drop in an allergic eye disease named vernal keratoconjunctivitis.

Phase 2
Conditions
Health Condition 1: H108- Other conjunctivitis
Registration Number
CTRI/2023/01/049304
Lead Sponsor
Department of Shalakya Tantra
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Males or females 4 to 18 years of age.

2.Active VKC

3.Patients were required to have experienced 1 or more recurrences of VKC during the previous year.

4.Only the patients (or patientâ??s guardian) who consent to be included in the study and sign on the consent form attached as annexure 1 will be included in the study.

Exclusion Criteria

1.Patients will be excluded if they demonstrated ocular anomalies other than VKC affecting the ocular surface.

2.Abnormalities of lid anatomic features, nasolacrimal drainage, or blinking function.

3.Active ocular infection or history of ocular herpes, varicella zoster or vaccinia virus infection.

4.Any ocular disease that would require topical ocular treatment during the study.

5.Presence or history of severe systemic allergy at study entry.

6.Topical or systemic corticosteroids within 1 week; topical or systemic immunosuppressive drug within 90 days before enrolment.

7.Scraping of the vernal plaque within 1 month; or any other ocular surgery within 6 months before baseline.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath